
₨ 47.00 ₨ 39.95

MBBS
OPTA CARPINE 4% Eye Drops 5ml
- Does this requires a prescription ? Yes
- Generic Name: Pilocarpine (HCl + Nitrate):4%w/v
- Manufactured by : Remington Pharma
- Drug Strength : 4%w/v
- Drug Form : Eye Drops
- Pack Size : 5ml
- Product SKU : dis_33919
Pilocarpine (HCl + Nitrate):4%w/v | Miotics
Manufactured / Marketed By : Remington Product Form : Eye DropsPack Size : 5mlIngredients : Pilocarpine (HCl + Nitrate):4%w/vGeneric Category : Miotics
How it works
OPTA CARPINE 4% Eye Drops 5ml works by increasing the secretion of saliva in the mouth. The ophthalmic form of this medicine works by reducing the fluid pressure inside the eyes as well as reducing the size of the pupil.
Side effects
Major & minor side effects for OPTA CARPINE 4% Eye Drops 5ml
- Increased sweating
- Tremors
- Nausea and vomiting
- Diarrhea
- Troubled breathing
- Watering of mouth
- Eye pain
- Blurred vision
- Eye irritation
- Headache
- Chills
- Runny Nose
- Frequent urination
- Dizziness
- Weakness
- Heartburn
- Stomach pain
- Fast or slow heartbeat rare
Uses of OPTA CARPINE 4% Eye Drops 5ml
What is it prescribed for?
-
Xerostomia
This medicine is used for the treatment of abnormal dryness of the mouth (xerostomia) in patients undergoing radiotherapy for head and neck cancer and in patients with a Sjogren's syndrome, condition that affects the immune system and causes dryness of mouth and eyes.
-
Intraocular hypertension
The ophthalmic form of this medicine is used to reduce fluid pressure inside the eyes for patients suffering from intraocular hypertension.
-
Open angle Glaucoma
The ophthalmic form of this medicine is used in the treatment of open-angle glaucoma, a condition characterized by progressive damage to the optic nerve that may eventually lead to vision loss.
-
Narrow-angle glaucoma
The ophthalmic form of this medicine is used in the treatment of narrow-angle glaucoma, a condition that occurs suddenly when the iris is pulled or pushed forward and there is a fluid build up behind the iris.
-
Production of miosis
The ophthalmic and intracameral (injection into the eye chamber) forms of this medicine are used for the production of miosis (excessive constriction of the pupil of the eye) prior to and during ophthalmic surgeries as necessary.
Concerns
Frequently asked questions
-
Onset of action
The effect of the oral form of this medicine can be observed within 20 minutes of administration of the dose. The effect of the ophthalmic form of this medicine can be observed within 10 to 30 minutes of administration of the dose. The effect of the intracameral form of this medicine (injection into the eye chamber) is rapid.
-
Duration of Effect
The effect of the oral form of this medicine lasts for an average duration of 3 to 5 hours. The effect of the ophthalmic form of this medicine lasts for an average duration of 4 to 8 hours. The amount of time for which the intracameral (injection into the eye chamber) form of this medicine remains active is not clinically established.
-
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
-
Is it habit forming?
No habit-forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
-
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to OPTA CARPINE 4% Eye Drops 5ml or any other inactive ingredients present along with this medicine.
-
Asthma
This medicine is not recommended for use in patients with uncontrolled asthma since it may worsen the patient's condition.
-
Uveitis
This medicine is not recommended for use in patients suffering from uveitis since it may worsen the patient's condition.
-
Undesirable pupillary constriction
This medicine is not recommended for use where pupillary constriction is undesirable such as acute iritis, anterior uveitis, etc.
-
Contact lens
This ophthalmic form of this medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration and can be reinserted after 10 to 15 minutes of administration of the dose.This ophthalmic form of this medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration and can be reinserted after 10 to 15 minutes of administration of the dose.
-
Driving or operating machines
This medicine may cause blurred vision and dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.
-
Dehydration
This medicine should be used with caution in patients who are known or expected to sweat excessively due to the increased risk of dehydration. Patients are advised to drink an adequate amount of water or liquids to maintain hydration.
-
Peptic ulcer
The oral form of this medicine should be used with caution in patients with peptic ulcer disease due to the increased risk of worsening of the patient's condition. Appropriate patient education, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
-
Renal impairment
The oral form of this medicine should be used with caution in patients with renal impairment due to the increased risk of severe adverse effects. Close monitoring of renal function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
-
Cardiovascular diseases
The oral form of this medicine should be used with caution in patients with cardiovascular diseases due to the increased risk of worsening of the patient's condition. Appropriate patient education, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
-
Pulmonary diseases
The oral form of this medicine should be used with caution in patients suffering from lung diseases such as controlled asthma, chronic bronchitis, or chronic obstructive pulmonary disease due to the increased risk of worsening of the patient's condition. Appropriate patient education, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Dosage
-
Missed Dose
Oral form: Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one. Eye drops: Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one. Injection: Since this medicine is administered by a qualified healthcare professional, the likelihood of missing a dose is very low.
-
Overdose
Oral form and eye drops: Seek emergency medical treatment or contact the doctor in case of an overdose. Injection: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Interactions
Interaction with Medicines- Atropine moderate
- Ipratropium moderate
- Loxapine moderate
- Atenolol moderate
- Clozapine moderate
-
severe
This medicine should be used with caution in patients with risk factors for retinal detachment such as old age, retinal degenerative changes or other retinal disorders, aphakia, prior cataract extraction, or a history of severe myopia or retinal detachment due to the increased risk of retinal detachment. Fundus examination is advised in all patients before starting therapy with this medicine. Replacement with a suitable alternative may be required based on the clinical condition of the patient.
-
severe
This medicine is not recommended for use in patients with uveitis due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.
-
moderate
This medicine should be used with caution in patients with or predisposed to cataracts due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition of the patient.
General Instructions
Oral form: Take this medicine with or without food. Do not consume in larger amounts than advised. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Eye drops: Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Injection: This medicine is administered by a qualified healthcare professional in the hospital setting. Inform the doctor if you have a known allergy to this medicine. Report to the doctor all your current medicines including herbs and supplements as well as all your medical conditions before receiving this medicine.
Other details
- Can be taken with or without food, as advised by your doctor
- To be taken as instructed by doctor
- Does not cause sleepiness
References
- medlineplus - Pilocarpine [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a608039.html [cited 2/17/2021]. 2021
One of the following licensed pharmacy from the nearest location will deliver OPTA CARPINE 4% Eye Drops 5ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Reviews
There are no reviews yet.